Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
Authors:
- Tiina JääskeläinenTJTiina Jääskeläinen
- Mikko PelkonenMPMikko Pelkonen
- Sami HeikkinenSHSami Heikkinen
- Sami VäisänenSVSami Väisänen
- Veli-Matti KosmaVKVeli-Matti Kosma
- Kaisa NieminenKNKaisa Nieminen
- Arto MannermaaAMArto Mannermaa
- Jorma J. PalvimoJPJorma J. Palvimo
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 365 (2) , 270-276
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast CancerThe American Journal of Pathology, 2011
- Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancyNucleic Acids Research, 2011
- Hormone Action in the Mammary GlandCold Spring Harbor Perspectives in Biology, 2010
- Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activityBMC Cancer, 2010
- A CTCF-independent role for cohesin in tissue-specific transcriptionGenome Research, 2010
- Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaOncogene, 2010
- Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanesMolecular Cancer Therapeutics, 2009
- Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein MicroarraysMolecular & Cellular Proteomics, 2009
- PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosisOncogene, 2009
- Delineation of prognostic biomarkers in prostate cancerNature, 2001